BMO Capital Positive on Abbvie (ABBV) Humira Win Versus Amgen (AMGN)
Go back to BMO Capital Positive on Abbvie (ABBV) Humira Win Versus Amgen (AMGN)| AbbVie (NYSE: ABBV) | Delayed: 250.33 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $250.33 | 52 Week High | $68.12 | |||
| Open | $250.33 | 52 Week Low | $50.71 | |||
| Day High | $250.33 | P/E | 54.30 | |||
| Day Low | $250.33 | EPS | $4.61 | |||
| Volume | 6,646 | |||||
| Amgen Inc (NASDAQ: AMGN) | Delayed: 419.38 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $419.38 | 52 Week High | $176.85 | |||
| Open | $419.38 | 52 Week Low | $133.64 | |||
| Day High | $419.38 | P/E | 63.16 | |||
| Day Low | $419.38 | EPS | $6.64 | |||
| Volume | 5,974 | |||||
